期刊文献+

上调基因-4对结肠癌细胞增殖的影响 被引量:3

Effects of up-regulated gene-4 on the proliferation of colonic cancer cells
原文传递
导出
摘要 目的探讨上调基因-4(URG-4)对结肠癌细胞增殖的影响。方法筛选高表达URG-4的结肠癌细胞。构建URG-4基因siRNA的逆转录病毒载体及阴性对照,经PT67细胞包装后,获得可表达人URG-4基因siRNA逆转录病毒及阴性对照。RT—PCR和Westernblot法检测MKN45、SW480、LoVo、HCT116、HT29细胞中URG-4mRNA和蛋白表达水平,筛选稳定转染细胞株。分别使用重组病毒(干扰组)、原始病毒(阴性对照组)和等量PBS(空白对照组)转染结肠癌LoVo细胞。MTT法检测各组结肠癌LoVo细胞生长情况。计量资料比较采用单因素方差分析和t检验。结果测序结果证实表达siRNA的逆转录病毒成功构建。URG-4mRNA在MKN45、SW480、LoVo、HCT116和HT29细胞中的相对表达量分别为0.58±0.02、0.63±0.03、0.81±0.01、1.01±0.02和0.91±0.04;URG-4蛋白相对表达量分别为0.73±0.02、0.85±0.03、1.42±0.01、0.80±0.03和0.80±0.04。结肠癌LoVo细胞高表达URG-4。干扰组中URG-4mRNA表达为0.55±0.03,显著低于阴性对照组的1.15±0.02和空白对照组的1.15±0.01(t=-5.179,-9.285,P〈0.05)。干扰组URG—dmRNA的抑制率为52.6%。干扰组中URG-4蛋白表达为0.82±0.05,显著低于阴性对照组的1.46±0.07和空白对照组的1.54±0.04(t=-4.239,-3.704,P〈0.05)。干扰组URG-4蛋白的抑制率为43.6%。各组结肠癌LoVo细胞呈指数生长。与阴性对照组比较,第3~6天干扰组细胞增殖受到明显抑制,差异有统计学意义(t=-6.436,-6.045,-6.434,-4.285,P〈0.05)。结论干扰URG-4表达能够抑制LoVo细胞的生长。 Objective To study the effects of up-regulated gene-4 (URG-4) on colon cancer cell proliferation. Methods Colon cancer cell line with high expression of URG-4 was selected. The recombinant URG-4 siRNA retroviral vector was constructed and packaged by PT67 cell, then retroviral particles which can express URG-4 siRNA in mammal cell and its negative control were obtained. Expressions of URG-4 in MKN45, SW480, LoVo, HCT116, HT29 were detected by RT-PCR and Western blot, respectively. Recombinant virus (interference group) , original virus (negative control group) and the same amount of PBS (blank group ) were used to transfect LoVo cells respectively. Stably transfected cell lines were screened. The growth condition of cell lines in each group was assayed by MTT. All data were analyzed by the one-way analysis of variance and the t test. Results Sequencing results confirmed the successful construction of retroviral which expressed siRNA, the relative expression levels of URG-4 mRNA in MKN45, SW480, LoVo, HCTll6, HT29 were 0.58 +0.02, 0.63 _+ 0.03, 0.81 ±0.01, 1.01 ±0.02, 0.91 +-0.04 and the expression levels of URG-4 protein in the 5 cell lines were 0.73 - 0.02, 0.85 ,+ 0.03, 1.42 ± 0.01, 0.80 ,+ 0.30, 0.80 ,+ 0.04, respectively. High expression of URG-4 was observed in the LoVo cells. The expression of URG-4 mRNA in the LoVo cells in the interference group was 0.55 ±0. 03, which was significantly lower than 1.15 ± 0.02 of the negative control group and 1.15±0.01 of the blank group (t =-5. 179, -9.285, P〈0.05) . The inhibition rate of URG-4 mRNA in the interference group was 52.6%. The expression of URG-4 protein in the interference group was 0.82 ± 0.05, which was significantly lower than 1.46 ± 0.07 of the negative control group and 1.54± 0.04 of the blank group ( t =- 4. 239, - 3. 704, P 〈 0.05). The inhibition rate of URG-4 protein in the interference group was 43.6%. The LoVo cells in each group grew exponentially. Compared with the negative control group, the cell growth of the interference group was inhibited during day 3 to day 6, - 6. 045, - 6. 434, - 4. 285, P 〈0. 05 ). Conclusion growth of LoVo cells. which had statistical significant difference ( t = - 6. 436, Interference of the expression of URG-4 can inhibit the growth of LoVo cells.
出处 《中华消化外科杂志》 CAS CSCD 北大核心 2012年第3期290-293,共4页 Chinese Journal of Digestive Surgery
基金 全军十一五课题(06MB243)
关键词 结肠肿瘤 逆转录病毒载体 RNA干扰 细胞增殖 Colonic neoplasms Retroviral vector RNA interference Cell proliferation
  • 相关文献

参考文献15

  • 1崔浩,张超,刘涛,王攀,徐建华.上调基因-4在结肠癌中的表达及临床意义[J].第三军医大学学报,2011,33(1):33-35. 被引量:4
  • 2Tufan NL, Lian Z, Liu J, et al. Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival. Neoplasia,2002,4 (4) :355-368.
  • 3童光东,周大桥,贺劲松,肖春玲,刘心亮,周小舟,张希,邢宇锋,吕屏,Mark A.Feitelson.乙型肝炎相关肝癌的癌前病变标志物检测及其意义[J].中华肝脏病杂志,2007,15(11):828-832. 被引量:13
  • 4Huang J, Zhu B, Lu L, et al. The expression of novel gene URG4 in osteosarcoma : correlation with patients' prognosis. Pathology, 2009,41 (2) :149-154.
  • 5Song J, Xie H, Lian Z, et al. Enhanced cell survival of gastric cancer cells by a novel gene URG4. Neoplasia,2006,8 ( 12 ) :995- 1002.
  • 6Tsang HT, Connell JW, Brown SE, et al. A systematic analysis of human CHMP protein interactions: additional MIT domain-containing proteins bind to multiple components of the human ESCRT III complex. Genomics,2006,88 (3) :333-346.
  • 7Shim JH, Xiao C, Hayden MS, et al. CHMP5 is essential for late endosome function and down-regulation of receptor signaling during mouse embryogenesis. J Cell Biol,2006,172(7) :1045-1056.
  • 8Ward DM, Vaughn MB, Shiflett SL, et al. The role of LIP5 and CHMP5 in muhivesicular body formation and HIV-1 budding in mammalian cells. J Biol Chem,2005,280( 11 ) :10548-10555.
  • 9Shim S, Merrill SA, Hanson PI. Novel interactions of ESCRT-III with LIP5 and VPS4 and their implications for ESCRT-III disassembly. Mol Biol Cell, 2008,19 ( 6 ) : 2661 - 2672.
  • 10Shahmoradgoli M, Mannherz O, Engel F, et al. Antiapoptotic function of charged multivesicular body protein 5 : a potentially relevant gene in acute myeloid leukemia. Int J Cancer,2011,128 (12) :2865-2871.

二级参考文献16

  • 1杨媛(综述),王蒙(综述),粟永萍(审校).RNAi作用机制研究进展及其应用[J].免疫学杂志,2005,21(6):543-545. 被引量:10
  • 2Tang H, Oishi N, Kaneko S, et al. Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci, 2006, 97: 977- 983.
  • 3Sanz-Cameno P, Martfn-Vflchez S, Lara-Pezzi E, et al. Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: role of HBV x protein. Am J Pathol, 2006, 169: 1215-1222.
  • 4Fujii R, Zhu C, Wen Y, et al. HBXIP cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. Cancer Res, 2006, 66: 9099-9107.
  • 5Tufan NL, Lian Z, Liu J, et al. Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival. Neoplasia, 2002, 4: 355-368.
  • 6Varecková E, Blaskovicová H, Gocnfk M, et al. Evaluation of clinical specimens for influenza A virus positivity using various diagnostic methods. Acta Virol, 2006, 50: 181-186.
  • 7Tackels-Home D, Goodman MD, Williams A J, et al. Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling. Cancer, 2001, 92: 395-405.
  • 8Jin YR, Hann HWL, Clayton MM, et al. Preneoplastic markers of hepatocarcinogenesis in hepatitis B virus carders. J Hepatol, 2002, 36: 184.
  • 9Lian Z, Liu J, Li L, et al. Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin. Hepatology, 2006, 43: 415-424.
  • 10Lian Z, Liu J, Pan J, et al. A cellular gene up-regulated by hepatitis B virus-encoded X antigen promotes hepatocellular growth and survival. Hepatology, 2001, 34: 146-157.

共引文献16

同被引文献15

  • 1Koebrugge B, Bosscha K, Liefers G J, et al. Can micrometastases be used to predict colon cancer prognosis? Hopes for the EnRoute+ study [J]. Expert Rev Gastroenterol Hepatol, 2011,5 (5) :559-561.
  • 2Yoshino H, Chiyomaru T, Enokida H, et al. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer[J]. Br J Cancer, 2011,104(5):808-818.
  • 3Ali NA, McKay MJ, Molloy MP. Proteomics of Smad4 regulated transforming growth factor-beta signalling in colon cancer cells[J]. Mol Biosyst, 2010,6 ( 11 ):2332-2338.
  • 4Chen XL, Zhou L, Yang J, et al. Hepatocellular carcinoma-associ- ated protein markers investigated by MALDI-TOF MS[J]. Molecular medicine reports, 2010,3 (4):589-596.
  • 5Ladd J, Taylor AD, Piliarik M, et al. Label-free detection of cancer biomarker candidates using surface plasmon resonance imaging [J]. Anal Bioanal Chem, 2009,393(4):1157-1163.
  • 6Nohata N, Hanazawa T, Kikkawa N, et al. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133ain maxillary sinus squamous cell carcinoma[J]. Int J Oncol, 2011,39 (5):1099-1107.
  • 7Xu SG, Yan PJ, Shao ZM. Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two- dimensional differential gel electrophoresis[J]. J Cancer Res Clin Oncol, 2010,136( 10):1545-1556.
  • 8Rho JH, Roehrl MH, Wang JY. Tissue proteomics reveals differen- tial and compartment-specific expression of the homologs trans- gelin and transgelin-2 in lung adenocarcinoma and its stroma[J]. J Proteome Res, 2009,8(12):5610-5618.
  • 9Chen J, Watanabe M, Huang P, etal. REIC/Dkk-3 stable trans- fection reduces the malignant phenotype of mouse prostate cancer RM9 cells[J]. Int J Mol Med, 2009,24(6):789-794.
  • 10Moriya Y, Nohata N, Kinoshita T, et al. Tumor suppressive mi- croRNA-133a regulates novel molecular networks in lung squa- mous cell carcinoma[J]. J Hum Genet, 2012,57 (1):38-45.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部